ContextVision refers to the financial calendar included in the Annual Report for 2025, published on 8th April 2026.
The date for the Q1 interim report was incorrectly stated in the Annual Report. The correct publication date for the Q1 interim report is 8th of May 2026, in line with previously communicated information to the market.
The financial calendar available on ContextVision’s website and via market data providers reflects the correct date.
No other dates or information are affected.
For further information, please contact:
Richard Hallström, CFO
Email: richard.hallstrom@contextvision.com
About ContextVision AB:
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.